Weekly Roundup: 15 Health Press Releases You Need to See
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
PMLiVE1d
EC approves CSL/Arcturus’ self-amplifying mRNA COVID-19 vaccine Kostaive
Jonathan Edelman, senior vice president of CSL’s vaccines innovation unit, said the approval “marks a significant milestone” ...
Arcturus Therapeutics price target raised to $48 from $41 at BTIG
BTIG raised the firm’s price target on Arcturus Therapeutics (ARCT) to $48 from $41 and keeps a Buy rating on the shares. The Kostaive ...
The Pharma Letter5d
The week in pharma: action, reaction and insight – week to February 14
Significant research news last week included a setback for Pliant Therapeutics, when it paused a Phase IIb trial of its bexotegrast in idiopathic pulmonary fibrosis (IPP). Also, US biotech AnaptysBio ...
The Pharma Letter6d
EC approves CSL and Arcturus’ Kostaive
The European Commission has granted marketing authorization for Kostaive (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, ...